IMARC Group, a leading market research company, has recently released a report titled “Newborn Screening Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global newborn screening market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
What Are The Growth Prospects Of The Newborn Screening Industry?
According to the report, The global newborn screening market size reached US$ 956 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,467 Million by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
What is Newborn Screening?
Newborn screening refers to the preventive healthcare program that identifies the risk of rare and severe medical conditions in babies. It is essential to test babies at birth to determine conditions, such as physical disabilities, brain damage, and other life-threatening diseases, which can affect their normal development. Newborn screening allows early intervention, which aids in the elimination and reduction of morbidity, mortality, and disability in affected newborns.
Request for a free sample copy of this report: https://www.imarcgroup.com/newborn-screening-market/requestsample
What are the growth prospects and trends in the Newborn Screening industry?
The global newborn screening market is primarily driven by the growing neonatal population and the increasing instances of congenital diseases in newborns. Besides this, various organizations, such as the World Health Organization (WHO), Center for Disease Control (CDC), and Healthy Newborn Network, are educating parents regarding the disorders and their diagnostic procedures. This helps prevent death in babies within the first month of their birth due to lack of skilled care and screening. Furthermore, governments in different countries are also funding programs introducing newborn screening and new treatment options, which is further expected to influence the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Product:
- Instruments
- Reagents
Breakup by Technology:
- Tandem Mass Spectrometry
- Pulse Oximetry
- Enzyme Based Assay
- DNA Assay
- Electrophoresis
- Others
Breakup by Test Type:
- Dry Blood Spot Test
- CCHD
- Hearing Screen
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Agilent Technologies Inc.
- Baebies Inc.
- Bio-RAD Laboratories Inc.
- Chromsystems Instruments & Chemicals GmbH
- Danaher Corporation
- Masimo Corporation
- Medtronic plc
- Natus Medical Incorporated
- Perkinelmer Inc.
- RECIPE Chemicals + Instruments GmbH
- Thermo Fisher Scientific Inc.
- Trivitron Healthcare
- Waters Corporation.
Ask Analyst for Free Sample Report: https://www.imarcgroup.com/request?type=report&id=4068&flag=F
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
